ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TERN Terns Pharmaceuticals Inc

7.09
-0.19 (-2.61%)
Jun 07 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 817,324
Bid Price 7.06
Ask Price 7.69
News -
Day High 7.5393

Low
3.26

52 Week Range

High
13.03

Day Low 7.06
Share Name Share Symbol Market Stock Type
Terns Pharmaceuticals Inc TERN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.19 -2.61% 7.09 19:00:00
Open Price Low Price High Price Close Price Previous Close
7.14 7.06 7.5393 7.15 7.28
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
8,650 817,324 US$ 7.32 US$ 5,981,906 - 3.26 - 13.03
Last Trade Type Quantity Price Currency
18:56:24 1 US$ 7.11 USD

Terns Pharmaceuticals (TERN) Options Flow Summary

Overall Flow

Bullish

Net Premium

154k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.50%

Terns Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
462.26M 64.65M - 0 -90.21M -1.40 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Terns Pharmaceuticals News

Date Time Source News Article
6/03/202415:10GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New..
5/30/202407:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming June..
5/17/202415:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in UBS Obesity..
5/13/202415:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202407:07Edgar (US Regulatory)Form 8-K - Current report
5/13/202407:05GlobeNewswire Inc.Terns Pharmaceuticals Reports First Quarter 2024 Financial..
5/08/202415:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Leadership Changes
5/07/202415:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in The Citizens JMP..
5/03/202415:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New..
4/29/202415:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Data from Ongoing Phase 1..
4/10/202415:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Melita Sun Jung as Chief..
3/14/202415:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Fourth Quarter and Full Year..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TERN Message Board. Create One! See More Posts on TERN Message Board See More Message Board Posts

Historical TERN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week7.107.69355.7156.551,835,846-0.01-0.14%
1 Month5.867.69355.476.351,005,7741.2320.99%
3 Months7.087.69354.325.94906,8960.010.14%
6 Months6.788.684.326.40821,8910.314.57%
1 Year12.1913.033.266.76762,402-5.10-41.84%
3 Years16.1619.971.457.07395,797-9.07-56.13%
5 Years16.9528.361.457.64371,384-9.86-58.17%

Terns Pharmaceuticals Description

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.

Your Recent History

Delayed Upgrade Clock